Your browser doesn't support javascript.
loading
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
Kageyama, Takahiro; Tanaka, Shigeru; Etori, Keishi; Hattori, Koto; Miyachi, Kazusa; Kasuya, Tadamichi; Iwamoto, Taro; Ikeda, Kei; Igari, Hidetoshi; Yokote, Koutaro; Nakajima, Hiroshi.
Afiliação
  • Kageyama T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Tanaka S; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Etori K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Hattori K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Miyachi K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kasuya T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Iwamoto T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Ikeda K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Igari H; Department of Infectious Diseases, Chiba University Hospital, Chiba, Japan; Chiba University Hospital COVID-19 Vaccine Center, Chiba, Japan.
  • Yokote K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Nakajima H; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Chiba University Hospital COVID-19 Vaccine Center, Chiba, Japan. Electronic address: nakajimh@faculty.chiba-u.jp.
Vaccine ; 40(14): 2129-2133, 2022 03 25.
Article em En | MEDLINE | ID: mdl-35241300

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Idioma: En Ano de publicação: 2022 Tipo de documento: Article